News
Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...
AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...
AstraZeneca has signed a research agreement worth more than $5 billion with Chinese drugmaker CSPC Pharmaceutical Group, the ...
AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for ...
CSPC will use its artificial-intelligence-driven, dual-engine efficient drug discovery platform to analyze the binding ...
A faulty lithium-ion battery in another Anker device has been linked to fires and explosions - here's how to check if yours ...
Hot Stocks}SANDS CHINA LTD quoted at HK$15.66, up 5.2% 17/06/2025 10:18 {Hot Stocks}SINO BIOPHARM quoted at HK$5.13, down 2.8% 17/06/2025 10:11 {Hot Stocks}CSPC PHARMA(01093) quoted at HK$8.49, down 3 ...
AstraZeneca said it entered into a strategic research collaboration with China’s CSPC Pharmaceuticals, focused on artificial intelligence-driven research, valued at up to $5.33 billion.
The drug licensing talks cover the development, production and sale of a targeted cancer therapy and other CSPC Pharma ...
Davey D and Lina Girl discuss the hottest trends in technology from gaming to life-saving devices to apps that make you ...
AstraZeneca will pay CSPC upfront fee of $110 million Additional potential payments of up to $5.22 billion to CSPC Deal latest of AstraZeneca efforts to bolster China business, AI The deal marks ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results